Related Experiment Video
Updated: Aug 14, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
HIV--associated lipodystrophy in children
Jens C Krause1, Mary P Toye, Barbara W Stechenberg
1Baystate Children's Hospital, Tufts University School of Medicine, Department of Pediatrics, 759 Chestnut Street, Springfield, MA 01199, USA.
Insights
Highly active antiretroviral therapy (HAART) can cause lipodystrophy (LD) in children with HIV. This review explores the roles of various hormones and cytokines in LD
Area of Science:
- Endocrinology
- Immunology
- Pediatric HIV
Background:
- Lipodystrophy (LD) is a complication of highly active antiretroviral therapy (HAART) in HIV-infected children.
- LD presents with lipohypertrophy, lipoatrophy, hyperlipidemia, and insulin resistance.
Purpose of the Study:
- To review the roles of leptin, adiponectin, growth hormone axis, glucocorticoids, SREBP-1c, TNF-alpha, IL-6, IL-18, IFN-alpha, tPA, and PAI-1 in the pathophysiology of LD.
- To elucidate the complex mechanisms underlying HAART-induced lipodystrophy in pediatric HIV.
Main Methods:
- Literature review and data summarization.
- Analysis of hormonal and cytokine profiles in pediatric LD.
Main Results:
- Adiponectin levels are typically decreased, while leptin levels are increased in LD.
- Glucocorticoids play a role in LD, despite normal systemic cortisol levels.
- Growth hormone resistance in LD requires further investigation.
Conclusions:
- Multiple factors, including hormones and cytokines, contribute to the pathophysiology of LD in HAART-treated children.
- Further research is needed to clarify the causal relationships between specific biomarkers and LD development.
Abstract:
Lipodystrophy (LD) with varying degrees of lipohypertrophy, lipoatrophy, hyperlipidemia, and insulin resistance is one of the complications of highly active antiretroviral therapy (HAART) and occurs in one to 33 % of HAART-treated, HIV infected children. We summarize the data on the role of leptin, adiponectin, the growth hormone axis, glucocorticoids, sterol response element binding protein 1c (SREBP-1c), the tumor necrosis factor alpha axis (TNF-alpha), interleukin-6 (IL-6), interleukin- 18 (IL-18), interferon-alpha (IFN-alpha), tissue plasminogen activator (tPA), and plasminogen activator inhibitor (PAI-1) in the pathophysiology of LD. Adiponectin levels are generally decreased in LD, whereas leptin levels are increased. Systemic cortisol levels are not elevated in LD, even though glucocorticoids seem to play an important role in LD and the phenotype can be reminiscent of Cushing syndrome. GH resistance in LD needs to be better characterized. While some cytokines show promise as markers for LD, it is difficult to tell whether their derangement is a cause of or the effect of LD.
Related Concept Videos
Retrovirus Life Cycles
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipid Digestion

